Clean utilities are a critical component of ensuring product quality and contamination control in pharmaceutical manufacturing. These systems are responsible for maintaining controlled environments engineered to maintain purity and uphold GMP standards, and as such, they must undergo rigorous qualification and validation testing, as well as ongoing monitoring, as required by international standards and regulations.
Compressed air is one of the most critical components of this system, playing a key role in several high-purity applications that range from direct product contact to packaging. Due to its direct-product-contact nature, it is essential to treat it with the same level of scrutiny as other critical systems and environments, such as water systems, to avoid contamination and compromising product quality and safety requirements. While we will mostly use the term “compressed air” throughout this article, it is important to clarify early on that compressed air can either be a clean utility, meaning air that comes into direct contact with products and processes, or a black utility, where it acts as a critical input for instrumentation and equipment without coming into direct contact with the product or process. Because these two roles are unique, they are not subject to the same purity requirements and must be approached differently from a regulatory perspective.